-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on WAVE Life Sciences, Lowers Price Target to $18

Benzinga·04/14/2026 11:05:19
Listen to the news
HC Wainwright & Co. analyst Andrew S. Fein maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $30 to $18.